| The regulation of iron absorption and homeostasis DF Wallace The Clinical Biochemist Reviews 37 (2), 51, 2016 | 293 | 2016 |
| Hepcidin: regulation of the master iron regulator G Rishi, DF Wallace, VN Subramaniam Bioscience reports 35 (3), e00192, 2015 | 267 | 2015 |
| Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload DF Wallace, L Summerville, EM Crampton, DM Frazer, GJ Anderson, ... Hepatology 50 (6), 1992-2000, 2009 | 240 | 2009 |
| Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis DF Wallace, P Pedersen, JL Dixon, P Stephenson, JW Searle, LW Powell, ... Blood 100 (2), 692-694, 2002 | 209 | 2002 |
| A simple genetic test identifies 90% of UK patients with haemochromatosis UK Haemochromatosis Consortium Gut 41 (6), 841-844, 1997 | 171 | 1997 |
| First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin DF Wallace, L Summerville, PE Lusby, VN Subramaniam Gut 54 (7), 980-986, 2005 | 169 | 2005 |
| A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote DF Wallace, JS Dooley, AP Walker Gastroenterology 116 (6), 1409-1412, 1999 | 151 | 1999 |
| Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload DF Wallace, L Summerville, VN Subramaniam Gastroenterology 132 (1), 301-310, 2007 | 139 | 2007 |
| Non-HFE haemochromatosis DF Wallace, VN Subramaniam World journal of gastroenterology: WJG 13 (35), 4690, 2007 | 124 | 2007 |
| Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis DF Wallace, RM Clark, HAJ Harley, VN Subramaniam Journal of hepatology 40 (4), 710-713, 2004 | 107 | 2004 |
| Uncommon mutations and polymorphisms in the hemochromatosis gene JJ Pointon, D Wallace, AT Merryweather-Clarke, KJH Robson Genetic testing 4 (2), 151-161, 2000 | 107 | 2000 |
| A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient KE Arden, DF Wallace, JL Dixon, L Summerville, JW Searle, GJ Anderson, ... Gut 52 (8), 1215-1217, 2003 | 99 | 2003 |
| The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data DF Wallace, VN Subramaniam Genetics in Medicine 18 (6), 618-626, 2015 | 89 | 2015 |
| Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype DF Wallace, JM Harris, VN Subramaniam American Journal of Physiology-Cell Physiology 298 (1), C75-C84, 2010 | 89 | 2010 |
| Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y DF Wallace, AP Walker, A Pietrangelo, M Clare, AB Bomford, JL Dixon, ... Journal of hepatology 36 (4), 474-479, 2002 | 70 | 2002 |
| Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron DF Wallace, VN Subramaniam Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (7), 663-670, 2009 | 67 | 2009 |
| Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease K Sandhu, K Flintoff, MD Chatfield, JL Dixon, LE Ramm, GA Ramm, ... Blood, blood-2018-02-830562, 2018 | 59 | 2018 |
| In Situ Proximity Ligation Assays Indicate That Hemochromatosis Proteins Hfe and Transferrin Receptor 2 (Tfr2) Do Not Interact G Rishi, EM Crampton, DF Wallace, VN Subramaniam PloS one 8 (10), e77267, 2013 | 57 | 2013 |
| Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis ZJ Hawula, DF Wallace, VN Subramaniam, G Rishi Pharmaceuticals 12 (4), 170, 2019 | 55 | 2019 |
| Iron storage disease in Asia‐Pacific populations: The importance of non‐HFE mutations CJ McDonald, DF Wallace, DHG Crawford, VN Subramaniam Journal of gastroenterology and hepatology 28 (7), 1087-1094, 2013 | 51 | 2013 |
